Daily Morning Note – 23 August 2021

Dear valued client,

Asian stocks look set to rise Monday after bargain hunters spurred a U.S. rally, with traders also weighing growth risks and awaiting the Jackson Hole symposium for clues on the Federal Reserve’s policy outlook.

Futures advanced in Japan, Australia and Hong Kong, while U.S. contracts edged higher. The S&P 500 and tech-heavy Nasdaq 100 rose at the end of last week. Beijing’s regulatory crackdown saw Chinese shares listed in the U.S. suffer their longest streak of weekly losses in a decade despite a climb on Friday.


SG News

Shares in Viking Offshore & Marine (VOM) will resume trading at 9 am on Aug 23, as the company has received approval-in principle (AIP) to do so from the Singapore Exchange (SGX). Trading in the shares in the company, which has completed a court-supervised restructuring exercise, has been suspended from trading on the SGX since June 14, 2019. In a filing to the Singapore bourse on Friday, VOM said that it has fulfilled all the AIP conditions set out.

Mapletree Logistics Trust (MLT) has entered into a new sale and purchase agreement to acquire Mapletree Logistics Hub – Tanjung Pelepas for RM404.8 million (S$130.2 million) after an agreement lapsed. In a filing to the Singapore Exchange on Friday, it said that the new conditional sale and purchase agreement had been entered into by Semangkuk 2, a bankruptcy-remote special purpose vehicle incorporated in Malaysia, with Trinity Bliss. Trinity Bliss is a company indirectly owned by Mapletree Investments (MIPL) and Itochu Corporation, with MIPL holding 80 per cent and Itochu the rest. As such, Trinity Bliss is a subsidiary of MIPL, which is also considered a controlling unitholder of MLT.

Astaka Holdings’ current executive director and former chief executive Zamani Bin Kasim has been ordered by the Singapore Exchange (SGX) to resign from all his current positions for causing the company to breach Catalist rules. SGX also reprimanded the group for failure to disclose three letters of demand relating to loan defaults. SGX, via a bourse filing on Friday, said it brought three charges against the Catalist-listed Astaka for failing to promptly disclose three letters of demand received by its wholly-owned indirect subsidiary, Astaka Padu Sdn Bhd (APSB), from China State Construction Engineering (CSCE) between October 2018 and July 2019.

US News

General Motors (GM) is recalling more than 73,000 of its Bolt electric vehicles (EVs) at a cost of US$1 billion due to the risk of their batteries catching fire. The recall is an expansion of a similar action the company took last month when it discovered a defect in the battery that powers the EV. The latest move covers all Bolt EVs and Bolt electric utility vehicles from the model years of 2019 through 2022, the automaker said in a statement Friday. GM is replacing the battery modules in those vehicles. Faced with the expanding recall, the automaker said it was pressing its battery supplier, South Korea’s LG Chem, “for reimbursement of this field action”. LG said it was working to ensure that the recall is carried out smoothly.

British retailer Marks & Spencer upgraded its profit outlook on Friday after a jump in demand for food and a surge in online clothes’ orders indicated that its latest turnaround plan was starting to deliver. Shares in the 137-year-old chain, one of the biggest names on the British high street, jumped 12 per cent as the company said it was enjoying more than just pent-up consumer demand that followed months of lockdowns and disruption during the pandemic. With a drive to improve the quality of products and heavy investment in technology and e-commerce, Marks & Spencer’s clothing and home division revenue almost doubled in the 19 weeks to Aug 14 from a year earlier and was down just 2.6 per cent on pre-pandemic 2019.

Cruise shares slipped in after-market trading late Friday after the Centers for Disease Control and Prevention (CDC) said high-risk travellers should avoid cruise ship travel, whether they are vaccinated or not. “Travelers who are at an increased risk of severe illness from Covid-19 should avoid travel on cruise ships, including river cruises, worldwide, regardless of vaccination status,” the CDC said in the updated guidance on Friday. The CDC defined those at heightened risk as older adults and those with underlying medical conditions and weakened immune systems. Authorities are still trying to grasp the full extent of so-called breakthrough infections, in which vaccinated people get sick. Hospital officials say the vast majority of those hospitalised and dying from the virus are unvaccinated.

Foot Locker shares soared more than 10% in early trading Friday after the company crushed analysts’ fiscal second-quarter earnings estimates and voiced optimism about the back half of the year. Consumers have continued to spend on athletic footwear and workout apparel during the Covid pandemic, with these segments outperforming others such as dress wear and high heels. Now, parents are budgeting their paychecks to buy new Nike and Adidas sneakers for their kids who are preparing to head back to school. Foot Locker reported net income for the quarter ended July 31 of $430 million, or $4.09 per share, compared with $45 million, or 43 cents per share, a year earlier. Excluding one-time gains, the company earned $2.21 per share. Analysts polled by Refinitiv were looking for adjusted earnings per share of $1.01.

Source: SGX Masnet, The Business Times, Bloomberg, Channel NewsAsia, Reuters, CNBC, PSR


Q & M Dental Group Ltd – Rebound on track

Recommendation: BUY (Maintained); TP S$0.98

Last close: S$0.775; Analyst Paul Chew

– 2Q21 PATMI within expectations, at 49% of our adjusted FY21e forecast. Revenue spiked 105% YoY to S$50.8mn. Normalised PATMI was up 10x. 1-for-5 bonus issue and 1 cent quarterly dividend announced.

– Earnings from Acumen Diagnostics’ COVID-19 PCR tests were an estimated S$3mn, up from S$0.6mn the previous quarter.

– Maintain BUY. Target price dips to S$0.98 from S$1.00 as we revamp our valuations. We now peg Acumen at S$60mn, at the proposed purchase price by Aoxin for a 49% stake. We roll over our 25x core P/E valuation to FY22e. Another S$0.04 has been added from the market value of listed associate, Aoxin Q & M Dental (S$0.225, Not Rated), at a 20% discount.

Thai Beverage PLC – Still in good spirits

Recommendation: BUY (Maintained); TP S$0.86

Last close: S$0.67; Analyst Paul Chew

– Results in line, with 9M21 revenue and EBITDA at 72%/75% of our FY21e forecasts.

– Spirits stole the limelight with a 21% YoY EBITDA surge, as volume recovered and costs were contained.

– Maintain BUY and target price of S$0.86, at 18x FY21e earnings, its 5-year average. Restricted on-premise consumption of beer and closure of F&B outlets to be compensated by resilience of spirit business together with aggressive cost-control. Spirits account for around 90% of PATMI. Catalysts expected from removal of lockdown measures in Thailand and Vietnam.

>> Read more research reports

HK Reports – Read up on our Hong Kong reports here

Webinar Of The Week

Weekly Market Outlook: SG Banks, SGX, First Sponsor, Pan-United, IREIT, Prime US, Lendlease……

Date: 16 Aug 2021

For more on Market Outlook

Updates summarised in 3 minutes

The Highlights EP01: LHN Limited – Optimisier of real-estate trends

For more videos on Phillip in 3 Mins

Read the research report(s), available through the link(s) above, for complete information including important disclosures Important Information

The information contained in this email and/or its attachment(s) is provided to you for information only and is not intended to or nor will it create/induce the creation of any binding legal relations. The information or opinions provided in this email do not constitute an investment advice, an offer or solicitation to subscribe for, purchase or sell the e investment product(s) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of this information. Investments are subject to investment risks including possible loss of the principal amount invested. The value of the product and the income from them may fall as well as rise. You may wish to seek advice from an independent financial adviser before making a commitment to purchase or investing in the investment product(s) mentioned herein. In the event that you choose not to do so, you should consider whether the investment product(s) mentioned herein is suitable for you. PhillipCapital and any of its members will not, in any event, be liable to you for any direct/indirect or any other damages of any kind arising from or in connection with your reliance on any information in and/or materials attached to this email. The information and/or materials provided 揳s is?without warranty of any kind, either express or implied. In particular, no warranty regarding accuracy or fitness for a purpose is given in connection with such information and materials.
Confidentiality Note
This e-mail and its attachment(s) may contain privileged or confidential information, which is intended only for the use of the recipient(s) named above. If you have received this message in error, please notify the sender immediately and delete all copies of it. If you are not the intended recipient, you must not read, use, copy, store, disseminate and/or disclose to any person this email and any of its attachment(s). PhillipCapital and its members will not accept legal responsibility for the contents of this message. Thank you for your cooperation.


Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you


This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  


Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com